Cutler Group LP Harpoon Therapeutics, Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.6 - $1.41 $360 - $846	600 New	600 $0
Q2 2022 Aug 04, 2022	SELL	$1.78 - $5.02 $4,862 - $13,714	-2,732 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$3.54 - $8.08 $1,062 - $2,424	-300 Reduced 9.89%	2,732 $13,000
Q4 2021 Jan 18, 2022	BUY	$5.69 - $7.83 $16,683 - $22,957	2,932 Added 2932.0%	3,032 $22,000
Q3 2021 Oct 26, 2021	BUY	$7.88 - $14.0 $788 - $1,400	100 New	100 $0

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.